Suppr超能文献

工程化丝氨酸蛋白酶抑制剂 α1-抗胰蛋白酶:多样化的目标和技术。

Engineering the serpin α -antitrypsin: A diversity of goals and techniques.

机构信息

Department of Chemistry and Biochemistry, University of Maryland, College Park, Maryland.

Biosystems and Biomaterials Division, National Institute of Standards and Technology, Gaithersburg, Maryland.

出版信息

Protein Sci. 2020 Apr;29(4):856-871. doi: 10.1002/pro.3794. Epub 2019 Dec 9.

Abstract

α -Antitrypsin (α -AT) serves as an archetypal example for the serine proteinase inhibitor (serpin) protein family and has been used as a scaffold for protein engineering for >35 years. Techniques used to engineer α -AT include targeted mutagenesis, protein fusions, phage display, glycoengineering, and consensus protein design. The goals of engineering have also been diverse, ranging from understanding serpin structure-function relationships, to the design of more potent or more specific proteinase inhibitors with potential therapeutic relevance. Here we summarize the history of these protein engineering efforts, describing the techniques applied to engineer α -AT, specific mutants of interest, and providing an appended catalog of the >200 α -AT mutants published to date.

摘要

α-1 抗胰蛋白酶(α-1-AT)是丝氨酸蛋白酶抑制剂(serpin)蛋白家族的典型范例,并且已经被用作蛋白质工程的支架超过 35 年。用于工程改造α-1-AT 的技术包括靶向诱变、蛋白融合、噬菌体展示、糖基工程和共识蛋白设计。工程的目标也多种多样,从了解 serpin 结构-功能关系,到设计更有效或更特异的蛋白酶抑制剂,具有潜在的治疗相关性。在这里,我们总结了这些蛋白质工程研究的历史,描述了应用于工程改造α-1-AT 的技术、感兴趣的特定突变体,并提供了迄今为止已发表的超过 200 种α-1-AT 突变体的附录目录。

相似文献

引用本文的文献

1
Expression and purification of a broad-spectrum human protease inhibitor in .广谱人蛋白酶抑制剂在……中的表达与纯化
Biochem Biophys Rep. 2025 Jun 15;43:102092. doi: 10.1016/j.bbrep.2025.102092. eCollection 2025 Sep.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验